SOMATIC RISK-FACTORS FOR INTERMEDIATE AND LONG-TERM SEQUELAE AFTER HEMATOLOGICAL STEM-CELL THERAPY PREDICTIVE FOR FEASIBILITY OF A REHABILITATION PROGRAM
W. Willenbacher et al., SOMATIC RISK-FACTORS FOR INTERMEDIATE AND LONG-TERM SEQUELAE AFTER HEMATOLOGICAL STEM-CELL THERAPY PREDICTIVE FOR FEASIBILITY OF A REHABILITATION PROGRAM, Onkologie, 21(3), 1998, pp. 217-223
Background: Hematological stem cell therapy (HSCT) is a major approach
with a curative potential for several hematologic malignancies and pe
rhaps also for solid tumors. Up to now there is almost no experience a
bout the feasibility, efficacy or cost effectiveness of rehabilitation
al efforts after HSCT. Moreover, no data exist about possible risk fac
tors, which might have a predictive value of the outcome of those stra
tegies. Patients and Methods: Between 1993-1997, a total of 207 patien
ts were included into a structured 4-6 weeks rehabilitation program af
ter allogenic pr autologous HSCT. All medical and transplantation data
were stored by online electronic data processing (EDP) and analyzed f
or subgroup characteristics and risk factors. Furthermore, odds ratios
were calculated. Results: We found life-threatening infections, trans
fusion dependency, myopathy, osteoporosis with fractures and hemorrhag
ic cystitis as dependend from transplantation procedures and the devel
opment of GvHD. 88% of patients were able to complete the entire rehab
ilitation program. 45% of patients who received allogenic HSCT and 44%
who had autologous HSCT did improve significantly as measured by Karn
ofsky Index. However, severe complications predominantly in patients w
ho had received allogenic, especially VUD-HSCT, demand intensive coope
ration with the entire facilities of a transplant center. Conclusions:
Prospective studies should be initiated to address the question of po
tential benefit and cost effectiveness of rehabilitational programs co
mpared to medical surveillance alone.